Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Photodynamic Therapy of Actinic Keratoses With Alacare®
Completed clinical trial evaluating Alacare-based photodynamic therapy for actinic keratosis, sponsored by photonamic GmbH & Co. KG.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Twelve Month Follow-Up of CP0108
A twelve-month follow-up update for CP0108 in Actinic keratosis, with the trial status reported as completed.
-
FDA approval · 2016-08-29FDA Approved: IMIQUIMOD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Imiquimod submitted by Sun Pharmaceutical Industries. This action typically updates labeling…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses [Phase 3]
This Phase 3 study evaluating the efficacy and safety of Actikerall Solution for grade I-II actinic keratoses has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis [Phase 2]
A Phase 2 trial evaluating topical photodynamic therapy with 5-aminolevulinic acid for actinic keratosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial comparing daylight-mediated photodynamic therapy using 0.2% hexyl aminolevulinate versus 16% methyl amino…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL) [Phase 4]
Phase 4 clinical trial comparing daylight photodynamic therapy using BF-200 ALA versus methyl aminolevulinate for actinic keratosis; results…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Actinic Keratosis Study [EARLY_Phase 1]
A Phase 1 study for actinic keratosis has completed.
-
FDA approval · 2016-05-10FDA Approved: AMELUZ — Original Application (Biofrontera Inc.)
The FDA approved AMELUZ (aminolevulinic acid hydrochloride) from Biofrontera for the topical treatment of actinic keratosis of the face and …
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp [Phase 3]
Phase 3 trial update for repeat use of ingenol mebutate gel 0.015% for actinic keratoses on the face and scalp. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses [Phase 3]
Phase 3 trial comparing Metvix Natural Daylight photodynamic therapy to conventional Metvix PDT in patients with actinic keratoses; results …
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis [Phase 2]
Phase 2 trial update of ACT01 in combination with Comp01-04 for actinic keratosis was completed with results posted on 2016-02-22.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment [Phase 3]
This update reports the completion of a Phase 3 efficacy and safety evaluation of SR-T100 Gel for actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis [Phase 1]
Phase 1 clinical trial update showing the efficacy of iontophoresis-assisted AFL-PDT for actinic keratosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses [Phase 2]
Phase 2 trial evaluated the safety of PEP005 topical gel at 0.025% and 0.05% in patients with actinic keratosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
An observational trial evaluating tolerability and efficacy of Resiquimod Gel in patients with actinic keratosis was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients [Phase 3]
A Phase 3 trial evaluating prevention of UV-induced carcinogenic skin alterations in immunosuppressed solid organ transplant patients was te…
-
FDA approval · 2016-01-07FDA Approved: LEVULAN KERASTICK — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for LEVULAN KERASTICK (aminolevulinic acid hydrochloride) from Sun Pharmaceutical Industries, expand…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel [Phase 4]
Phase 4 trial comparing photodynamic therapy with methyl aminolevulinate cream versus 5-aminolevulinic acid gel for actinic keratosis, asses…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions [Phase 2]
A Phase 2 dose-finding study evaluated the safety and efficacy of topical resiquimod in patients with multiple actinic keratosis lesions. Th…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant [Phase 2]
Phase 2 trial evaluating T4N5 liposomal lotion to prevent recurrence of nonmelanoma skin cancer in kidney transplant patients; the study has…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities [Phase 3]
Phase 3 trial evaluating safety and efficacy of photodynamic therapy with Levulan Kerastick and blue light for actinic keratoses on the uppe…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 [Phase 1]
Phase 1 update reporting safety and tolerability of PEP005 topical gel applied to up to 100 cm2 in Actinic Keratosis patients.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects [Phase 1]
Phase 1 trial evaluating local tolerability of ingenol mebutate gel (PEP005 Gel) after exposure followed by hand washing in healthy subjects…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating the photoallergic potential of PEP005 (ingenol mebutate) gel 0.01% in healthy volunteers has completed.